Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer [Phase 1]
A Phase 1 trial of a biological therapy for metastatic melanoma or metastatic kidney cancer has completed its status/enrollment.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
A terminated clinical trial update studying soluble and cellular biomarkers and functional imaging during antiangiogenic therapies in cancer…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) [Phase 2]
A Phase 2 clinical trial evaluating radiofrequency interstitial tissue ablation for localized renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
This clinical trial update describes factors that may influence disease progression and treatment outcomes in patients with tumors of the pr…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection [Phase 1]
Phase 1 safety study of cord blood–derived cytokine-induced killer (CIK) cells in patients with solid tumors after radical resection. The li…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma [Phase 2]
A Phase II study in advanced renal cell carcinoma has completed. This entry serves as a trial update for the study.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating the combination of sunitinib and gemcitabine in sarcomatoid or poor-risk metastatic renal cell carcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma [Phase 4]
An update on a Phase 4 trial evaluating biomarkers in the first-line treatment of metastatic renal cell carcinoma, which has been terminated…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Cardiovascular and Torsades de Pointes Monitoring for Pazopanib
This clinical trial update reviews cardiovascular safety monitoring for pazopanib, including Torsades de Pointes risk. It pertains to patien…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer [NA]
A clinical trial comparing clamped versus unclamped surgery for recurrent renal cell carcinoma has been terminated before completion.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival
A completed retrospective real-world study of sunitinib in metastatic renal cell carcinoma examines how dose variation affects duration of r…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluates safety and preliminary efficacy of a vaccine made from dendritic cells combined with tumor cells for ad…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies [Phase 1]
A Phase 1 study of MDX-1106 in patients with selected refractory or relapsed malignancies has completed, with results posted in 2015. The tr…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
Phase 2 study of bevacizumab in patients with unresectable or metastatic kidney cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma [Phase 1]
Phase Ib study evaluating the combination of RAD001 (everolimus) and Sutent (sunitinib) for renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy [Phase 2]
Phase 2 trial evaluating a novel controlled hypo-perfusion technique during partial nephrectomy has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer [NA]
Clinical trial evaluating the combination of sunitinib and surgery for localized or metastatic kidney cancer; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update for Tandutinib in patients who had surgery for metastatic renal cell carcinoma, including clear cell and recurrent dise…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation [NA]
A completed clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and alemtuzumab for patients with recurrent or…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
The update covers Nexavar (sorafenib) as the first targeted therapy in patients with advanced renal cell carcinoma, reporting results from a…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer [Phase 2]
Phase 2 safety and toxicity study of sorafenib in patients with renal cell carcinoma completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma [Phase 3]
Phase III, open-label, non-comparative study of BAY 43-9006 (sorafenib) as second-line therapy after first-line treatment in patients with a…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib [Phase 4]
A Phase IV randomized trial evaluating sustained sorafenib treatment in renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma [Phase 1, Phase 2]
Clinical trial update for lenalidomide in combination with sunitinib in renal cell carcinoma shows terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: BAY43-9006 Phase II Study for Renal Cell Carcinoma [Phase 2]
Phase II study of BAY43-9006 (sorafenib) for renal cell carcinoma has completed.